354 related articles for article (PubMed ID: 21729678)
1. Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.
Bolton JS; O'Connell MJ; Mahoney MR; Farr GH; Fitch TR; Maples WJ; Nagorney DM; Rubin J; Fuloria J; Steen PD; Alberts SR
Clin Colorectal Cancer; 2012 Mar; 11(1):31-7. PubMed ID: 21729678
[TBL] [Abstract][Full Text] [Related]
2. Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66.
Alberts SR; Roh MS; Mahoney MR; O'Connell MJ; Nagorney DM; Wagman L; Smyrk TC; Weiland TL; Lai LL; Schwarz RE; Molina R; Dentchev T; Bolton JS
J Clin Oncol; 2010 Feb; 28(5):853-8. PubMed ID: 20048179
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer.
Kemeny N; Capanu M; D'Angelica M; Jarnagin W; Haviland D; Dematteo R; Fong Y
Ann Oncol; 2009 Jul; 20(7):1236-41. PubMed ID: 19233901
[TBL] [Abstract][Full Text] [Related]
4. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
Kemeny N; Conti JA; Sigurdson E; Cohen A; Seiter K; Lincer R; Niedzwiecki D; Botet J; Chapman D; Costa P
Cancer; 1993 Mar; 71(6):1964-71. PubMed ID: 8443746
[TBL] [Abstract][Full Text] [Related]
6. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
7. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA
Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
[TBL] [Abstract][Full Text] [Related]
11. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
House MG; Kemeny NE; Gönen M; Fong Y; Allen PJ; Paty PB; DeMatteo RP; Blumgart LH; Jarnagin WR; D'Angelica MI
Ann Surg; 2011 Dec; 254(6):851-6. PubMed ID: 21975318
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
[TBL] [Abstract][Full Text] [Related]
13. Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: a phase II trial using intermittent percutaneous hepatic arterial access.
Copur MS; Capadano M; Lynch J; Goertzen T; McCowan T; Brand R; Tempero M
J Clin Oncol; 2001 May; 19(9):2404-12. PubMed ID: 11331319
[TBL] [Abstract][Full Text] [Related]
14. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
Lorenz M; Müller HH
J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
[TBL] [Abstract][Full Text] [Related]
15. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.
Ammori JB; Kemeny NE; Fong Y; Cercek A; Dematteo RP; Allen PJ; Kingham TP; Gonen M; Paty PB; Jarnagin WR; D'Angelica MI
Ann Surg Oncol; 2013 Sep; 20(9):2901-7. PubMed ID: 23771246
[TBL] [Abstract][Full Text] [Related]
16. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
O'Connell MJ; Nagorney DM; Bernath AM; Schroeder G; Fitzgibbons RJ; Mailliard JA; Burch P; Bolton JS; Colon-Otero G; Krook JE
J Clin Oncol; 1998 Jul; 16(7):2528-33. PubMed ID: 9667274
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y
J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951
[TBL] [Abstract][Full Text] [Related]
18. Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy.
Kemeny NE; Chou JF; Boucher TM; Capanu M; DeMatteo RP; Jarnagin WR; Allen PJ; Fong YC; Cercek A; D'Angelica MI
J Surg Oncol; 2016 Apr; 113(5):477-84. PubMed ID: 26830685
[TBL] [Abstract][Full Text] [Related]
19. Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.
Allard MA; Sebagh M; Baillie G; Lemoine A; Dartigues P; Faitot F; Faron M; Boige V; Vitadello F; Vibert E; Elias D; Adam R; Goéré D; Sa Cunha A
Ann Surg Oncol; 2015; 22(6):1925-32. PubMed ID: 25448804
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen).
Lorenz M; Müller HH; Schramm H; Gassel HJ; Rau HG; Ridwelski K; Hauss J; Stieger R; Jauch KW; Bechstein WO; Encke A
Ann Surg; 1998 Dec; 228(6):756-62. PubMed ID: 9860474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
